134 related articles for article (PubMed ID: 30403578)
1. Simple Inclusion of Complex Diagnostic Algorithms in Infectious Disease Models for Economic Evaluation.
Dodd PJ; Pennington JJ; Bronner Murrison L; Dowdy DW
Med Decis Making; 2018 Nov; 38(8):930-941. PubMed ID: 30403578
[TBL] [Abstract][Full Text] [Related]
2. A dynamic Bayesian Markov model for health economic evaluations of interventions in infectious disease.
Haeussler K; den Hout AV; Baio G
BMC Med Res Methodol; 2018 Aug; 18(1):82. PubMed ID: 30068316
[TBL] [Abstract][Full Text] [Related]
3. Critical issues in the economic evaluation of interventions against communicable diseases.
Hutubessy RC; Bendib LM; Evans DB
Acta Trop; 2001 Mar; 78(3):191-206. PubMed ID: 11311183
[TBL] [Abstract][Full Text] [Related]
4. Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems.
Main C; Moxham T; Wyatt JC; Kay J; Anderson R; Stein K
Health Technol Assess; 2010 Oct; 14(48):1-227. PubMed ID: 21034668
[TBL] [Abstract][Full Text] [Related]
5. [Mathematical modelling of an infectious disease in a prison setting and optimal preventative control strategies].
Trujillo-Salazar CA; Toro-Zapata HD; Muñoz-Loaiza A
Rev Salud Publica (Bogota); 2013; 15(6):943-56. PubMed ID: 25124356
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach.
Langley I; Lin HH; Egwaga S; Doulla B; Ku CC; Murray M; Cohen T; Squire SB
Lancet Glob Health; 2014 Oct; 2(10):e581-91. PubMed ID: 25304634
[TBL] [Abstract][Full Text] [Related]
7. Dynamic Transmission Economic Evaluation of Infectious Disease Interventions in Low- and Middle-Income Countries: A Systematic Literature Review.
Drake TL; Devine A; Yeung S; Day NP; White LJ; Lubell Y
Health Econ; 2016 Feb; 25 Suppl 1(Suppl Suppl 1):124-39. PubMed ID: 26778620
[TBL] [Abstract][Full Text] [Related]
8. Modelling the epidemiology of infectious diseases for decision analysis: a primer.
Jit M; Brisson M
Pharmacoeconomics; 2011 May; 29(5):371-86. PubMed ID: 21504239
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of option B+ in prevention of mother-to-child transmission of HIV in Yunnan Province, China.
Wang X; Guo G; Zheng J; Lu L
BMC Infect Dis; 2019 Jun; 19(1):517. PubMed ID: 31185927
[TBL] [Abstract][Full Text] [Related]
10. Do different decision-analytic modeling approaches produce different results? A systematic review of cross-validation studies.
Tsoi B; Goeree R; Jegathisawaran J; Tarride JE; Blackhouse G; O'Reilly D
Expert Rev Pharmacoecon Outcomes Res; 2015 Jun; 15(3):451-63. PubMed ID: 25728942
[TBL] [Abstract][Full Text] [Related]
11. Health economic and infectious disease modelling: a guide to merging streams.
Anonychuk A; Krahn M
Pharmacoeconomics; 2011 May; 29(5):367-9. PubMed ID: 21504238
[No Abstract] [Full Text] [Related]
12. Enhancing Decision Support for Vector-Borne Disease Control Programs--The Disease Data Management System.
Thomsen EK; Deb RM; Dunkley S; Coleman M; Foster G; Orlans M; Coleman M
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004342. PubMed ID: 26890287
[No Abstract] [Full Text] [Related]
13. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.
Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I
BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797
[TBL] [Abstract][Full Text] [Related]
14. A simplified cost-effectiveness model to guide decision-making for shortened anti-tuberculosis treatment regimens.
Zwerling A; Gomez GB; Pennington J; Cobelens F; Vassall A; Dowdy DW
Int J Tuberc Lung Dis; 2016 Feb; 20(2):257-60. PubMed ID: 26792481
[TBL] [Abstract][Full Text] [Related]
15. Markov Influence Diagrams.
Díez FJ; Yebra M; Bermejo I; Palacios-Alonso MA; Calleja MA; Luque M; Pérez-Martín J
Med Decis Making; 2017 Feb; 37(2):183-195. PubMed ID: 28076183
[TBL] [Abstract][Full Text] [Related]
16. Theoretical Foundations and Practical Applications of Within-Cycle Correction Methods.
Elbasha EH; Chhatwal J
Med Decis Making; 2016 Jan; 36(1):115-31. PubMed ID: 26092831
[TBL] [Abstract][Full Text] [Related]
17. Disparities in model-based cost-effectiveness analyses of tuberculosis diagnosis: A systematic review.
Padmasawitri TIA; Frederix GW; Alisjahbana B; Klungel O; Hövels AM
PLoS One; 2018; 13(5):e0193293. PubMed ID: 29742106
[TBL] [Abstract][Full Text] [Related]
18. Infectious disease screening in asylum seekers: range, coverage and economic evaluation in Germany, 2015.
Bozorgmehr K; Wahedi K; Noest S; Szecsenyi J; Razum O
Euro Surveill; 2017 Oct; 22(40):. PubMed ID: 29019315
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness Analysis with Influence Diagrams.
Arias M; Díez FJ
Methods Inf Med; 2015; 54(4):353-8. PubMed ID: 25762363
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.
Walusimbi S; Kwesiga B; Rodrigues R; Haile M; de Costa A; Bogg L; Katamba A
BMC Health Serv Res; 2016 Oct; 16(1):563. PubMed ID: 27724908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
